320 related articles for article (PubMed ID: 31830764)
1. Immune Thrombocytopenia in Adults: Modern Approaches to Diagnosis and Treatment.
Al-Samkari H; Kuter DJ
Semin Thromb Hemost; 2020 Apr; 46(3):275-288. PubMed ID: 31830764
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
3. Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice.
Song F; Al-Samkari H
J Blood Med; 2021; 12():653-664. PubMed ID: 34345191
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review.
Agarwal N; Mangla A
Ther Adv Hematol; 2021; 12():20406207211001139. PubMed ID: 33796239
[TBL] [Abstract][Full Text] [Related]
5. Current approaches for the diagnosis and management of immune thrombocytopenia.
Gafter-Gvili A
Eur J Intern Med; 2023 Feb; 108():18-24. PubMed ID: 36424271
[TBL] [Abstract][Full Text] [Related]
6. Immune Thrombocytopenia in Children: Consensus and Controversies.
Singh G; Bansal D; Wright NAM
Indian J Pediatr; 2020 Feb; 87(2):150-157. PubMed ID: 31927692
[TBL] [Abstract][Full Text] [Related]
7. Immune thrombocytopenia.
Bussel J; Cooper N; Boccia R; Zaja F; Newland A
Expert Rev Hematol; 2021 Nov; 14(11):1013-1025. PubMed ID: 34720027
[TBL] [Abstract][Full Text] [Related]
8. Older Adults and Immune Thrombocytopenia: Considerations for the Clinician.
Crickx E; Mahévas M; Michel M; Godeau B
Clin Interv Aging; 2023; 18():115-130. PubMed ID: 36726813
[TBL] [Abstract][Full Text] [Related]
9. The role of romiplostim for pediatric patients with immune thrombocytopenia.
Al-Samkari H; Grace RF; Kuter DJ
Ther Adv Hematol; 2020; 11():2040620720912992. PubMed ID: 32523658
[TBL] [Abstract][Full Text] [Related]
10. Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate.
Stasi R; Newland A; Thornton P; Pabinger I
Ann Hematol; 2010 Dec; 89(12):1185-95. PubMed ID: 20842501
[TBL] [Abstract][Full Text] [Related]
11. The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a "real life" retrospective multicenter experience of the Rete Ematologica Pugliese (REP).
Mazza P; Minoia C; Melpignano A; Polimeno G; Cascavilla N; Di Renzo N; Specchia G
Ann Hematol; 2016 Jan; 95(2):239-44. PubMed ID: 26596973
[TBL] [Abstract][Full Text] [Related]
12. The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim.
Deuson R; Danese M; Mathias SD; Schoonen M; Fryzek J
J Med Econ; 2012; 15(5):956-76. PubMed ID: 22533524
[TBL] [Abstract][Full Text] [Related]
13. Current and emerging treatments for immune thrombocytopenia.
Dou X; Yang R
Expert Rev Hematol; 2019 Sep; 12(9):723-732. PubMed ID: 31237783
[No Abstract] [Full Text] [Related]
14. Is there any Role for Splenectomy in Adulthood Onset Chronic Immun e Thrombocytopenia in the Era of TPO Receptors Agonists? A Critic al Overview.
Vibor M; Rogulj IM; Ostojic SK
Cardiovasc Hematol Disord Drug Targets; 2017 Jul; 17(1):38-51. PubMed ID: 28034281
[TBL] [Abstract][Full Text] [Related]
15. Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of Use.
Gilbert MM; Grimes AB; Kim TO; Despotovic JM
Patient Prefer Adherence; 2020; 14():1237-1250. PubMed ID: 32801654
[TBL] [Abstract][Full Text] [Related]
16. Chronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist.
Osman ME
Sudan J Paediatr; 2012; 12(2):60-4. PubMed ID: 27493347
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
Depré F; Aboud N; Mayer B; Salama A
PLoS One; 2018; 13(6):e0198184. PubMed ID: 29856800
[TBL] [Abstract][Full Text] [Related]
18. Childhood immune thrombocytopenia: Clinical presentation and management.
Faki Osman ME
Sudan J Paediatr; 2012; 12(1):27-39. PubMed ID: 27493327
[TBL] [Abstract][Full Text] [Related]
19. Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia.
Garzon AM; Mitchell WB
Front Pediatr; 2015; 3():70. PubMed ID: 26322297
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
Zaja F; Barcellini W; Cantoni S; Carpenedo M; Caparrotti G; Carrai V; Di Renzo N; Santoro C; Di Nicola M; Veneri D; Simonetti F; Liberati AM; Ferla V; Paoloni F; Crea E; Volpetti S; Tuniz E; Fanin R
Am J Hematol; 2016 May; 91(5):E293-5. PubMed ID: 26910388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]